1-(3-羟基苯基)-3-苯基硫脲 | 17073-35-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 1-(3-羟基苯基)-3-苯基硫脲
• 英文名称: N-phenyl-N'-3-hydroxyphenylthiourea
• 英文别名: PTU-23；N-(3-hydroxy-phenyl)-N'-phenyl-thiourea；N-(3-Hydroxy-phenyl)-N'-phenyl-thioharnstoff；1-(3-hydroxyphenyl)-3-phenyl-2-thiourea；1-(3-hydroxyphenyl)-3-phenylthiourea
• CAS: 17073-35-7
• 化学式: C₁₃H₁₂N₂OS
• 分子量: 244.317
• InChiKey: BTFREYNHBKXMCJ-UHFFFAOYSA-N

物化性质

• 沸点：
  403.4±47.0 °C(Predicted)
• 密度：
  1.386±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  76.4
• 氢给体数：
  3
• 氢受体数：
  2

安全信息

• 海关编码：
  2930909090

反应信息

• 作为产物：
  描述：

  3-氨基苯磺酸 在 sodium hydroxide 、 乙醇 、 水 作用下， 生成 1-(3-羟基苯基)-3-苯基硫脲
  参考文献：
  名称：

  Meyer,R.; Sundmacher, Chemische Berichte, 1899, vol. 32, p. 2123

  摘要：

  DOI：

文献信息

• Two-component initiator system (amine-free) with very good storage stability and particular suitability for acid systems
  申请人：Utterodt Andreas

  公开号：US20070040151A1

  公开（公告）日：2007-02-22

  A two-component initiator system having accelerators for curing polymerizable materials comprising the following components: (a) a hydroperoxide compound containing one or more hydroperoxide groups that are bound to a tertiary carbon; (b) a thiourea derivative; and (c) as accelerator, a copper compound which is soluble in the preparation is preferably free of amine and is particularly suited for polymerizable dental compositions.
• CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
  申请人：Sheridan Joseph M.

  公开号：US20140031547A1

  公开（公告）日：2014-01-30

  The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
• CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES SUCH AS TAUOPATHIES
  申请人：Electrophoretics Limited

  公开号：US20160354375A1

  公开（公告）日：2016-12-08

  The invention relates to pharmaceutical compositions comprising casein kinase 1 delta (CK1δ) and to the use of said inhibitors in the treatment of neurodegenerative disorders such as Alzheimer's disease.
• US4048333A
  申请人：——

  公开号：US4048333A

  公开（公告）日：1977-09-13
• Meyer,R.; Sundmacher, Chemische Berichte, 1899, vol. 32, p. 2123
  作者：Meyer,R.、Sundmacher

  DOI：——

  日期：——